Robert A. Harrington

4.2k total citations · 3 hit papers
58 papers, 2.7k citations indexed

About

Robert A. Harrington is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Hematology. According to data from OpenAlex, Robert A. Harrington has authored 58 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cardiology and Cardiovascular Medicine, 33 papers in Internal Medicine and 15 papers in Hematology. Recurrent topics in Robert A. Harrington's work include Venous Thromboembolism Diagnosis and Management (33 papers), Atrial Fibrillation Management and Outcomes (20 papers) and Acute Myocardial Infarction Research (16 papers). Robert A. Harrington is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (33 papers), Atrial Fibrillation Management and Outcomes (20 papers) and Acute Myocardial Infarction Research (16 papers). Robert A. Harrington collaborates with scholars based in United States, Canada and United Kingdom. Robert A. Harrington's co-authors include Robert M. Califf, Samuel Z. Goldhaber, Adrian F. Hernandez, Russell D. Hull, Eric D. Peterson, John G. McHutchison, Kevin A. Schulman, Seth W. Glickman, Charles B. Cairns and C. Michael Gibson and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Robert A. Harrington

56 papers receiving 2.5k citations

Hit Papers

Ethical and Scientific Implications of the Globalization ... 2009 2026 2014 2020 2009 2016 2023 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ethical and Scientific Implications of the Globalization of Clinical Research
    2009 458 citations Seth W. Glickman, John G. McHutchison et al. New England Journal of Medicine profile →
  2. Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients
    2016 320 citations Robert A. Harrington, Samuel Z. Goldhaber et al. New England Journal of Medicine profile →
  3. Food Is Medicine: A Presidential Advisory From the American Heart Association
    2023 84 citations Robert A. Harrington et al. Circulation profile →

Peers

Robert A. Harrington
Sanjit S. Jolly Canada
Sarah H. O’Brien United States
Robert C. Pendleton United States
Flemming Hald Steffensen Denmark
Daniela Poli Italy
David F.M. Brown United States
Ji Zhou China
Lara A Kahale Lebanon
Christine Demers Canada
Sunil Agarwal United States
Sanjit S. Jolly Canada
Robert A. Harrington
Citations per year, relative to Robert A. Harrington Robert A. Harrington (= 1×) peers Sanjit S. Jolly

Countries citing papers authored by Robert A. Harrington

Since Specialization
Citations

This map shows the geographic impact of Robert A. Harrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Harrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Harrington more than expected).

Fields of papers citing papers by Robert A. Harrington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Harrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Harrington. The network helps show where Robert A. Harrington may publish in the future.

Co-authorship network of co-authors of Robert A. Harrington

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Harrington. A scholar is included among the top collaborators of Robert A. Harrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Harrington. Robert A. Harrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chi, Gerald, Francesco Violi, Pasquale Pignatelli, et al.. (2022). External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX Trial. Journal of Thrombosis and Thrombolysis. 55(2). 211–221. 5 indexed citations
3.
Mou, Eric, Ilana B. Richman, Andre Kumar, et al.. (2019). Thrombophilia testing in the inpatient setting: impact of an educational intervention. BMC Medical Informatics and Decision Making. 19(1). 167–167. 8 indexed citations
4.
Cheung, Lauren, Tiffany I. Leung, Victoria Y. Ding, et al.. (2018). Healthcare Service Utilization under a New Virtual Primary Care Delivery Model. Telemedicine Journal and e-Health. 25(7). 551–559. 19 indexed citations
5.
Chi, Gerald, C. Michael Gibson, Adrian F. Hernandez, et al.. (2018). Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy. The American Journal of Medicine. 131(8). 972.e1–972.e7. 39 indexed citations
6.
Gibson, C. Michael, Tarek Nafee, Samuel Z. Goldhaber, et al.. (2017). Abstract 20393: Full-Dose Betrixaban Reduces Venous Thromboembolism-Related Mortality: An APEX Trial Substudy. Circulation. 2 indexed citations
7.
Yee, Megan K., Tarek Nafee, Yazan Daaboul, et al.. (2017). Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial. Journal of Thrombosis and Thrombolysis. 45(1). 1–8. 10 indexed citations
8.
Chi, Gerald, Samuel Z. Goldhaber, John M. Kittelson, et al.. (2017). Effect of extended‐duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis. Journal of Thrombosis and Haemostasis. 15(10). 1913–1922. 18 indexed citations
9.
Chi, Gerald, Tarek Nafee, Samuel Z. Goldhaber, et al.. (2017). Abstract 20322: Extended-Duration Betrixaban Reduces the Risk of Venous Thromboembolism-Related Rehospitalization Among Acutely Ill Hospitalized Medical Patients: An APEX Trial Substudy. Circulation. 1 indexed citations
10.
Chi, Gerald, Samuel Z. Goldhaber, Russell D. Hull, et al.. (2017). Thrombus Burden of Deep Vein Thrombosis and Its Association with Thromboprophylaxis and D-Dimer Measurement: Insights from the APEX Trial. Thrombosis and Haemostasis. 117(12). 2389–2395. 18 indexed citations
11.
Gibson, C. Michael, Tarek Nafee, Megan K. Yee, et al.. (2017). Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients. American Heart Journal. 198. 84–90. 16 indexed citations
12.
Gibson, C. Michael, Rim Halaby, Serge Korjian, et al.. (2016). The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial. American Heart Journal. 185. 93–100. 39 indexed citations
13.
Cohen, Alexander T, Robert A. Harrington, Samuel Z. Goldhaber, et al.. (2013). The design and rationale for the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) study. American Heart Journal. 167(3). 335–341. 71 indexed citations
14.
Mehta, Rajendra H., T. Bruce Ferguson, Renato D. Lópes, et al.. (2011). Saphenous Vein Grafts With Multiple Versus Single Distal Targets in Patients Undergoing Coronary Artery Bypass Surgery. Circulation. 124(3). 280–288. 66 indexed citations
15.
Cohen, Mauricio G., Drew A. Purdy, Joseph S. Rossi, et al.. (2010). FACTOR IXA INHIBITION WITH REG1 PROVIDES RAPID ONSET, STABLE AND ACTIVELY CONTROLLED ANTICOAGULATION DURING PCI. Journal of the American College of Cardiology. 55(10). A206.E1940–A206.E1940. 1 indexed citations
16.
Glickman, Seth W., John G. McHutchison, Eric D. Peterson, et al.. (2009). Ethical and Scientific Implications of the Globalization of Clinical Research. New England Journal of Medicine. 360(8). 816–823. 458 indexed citations breakdown →
17.
Hirsh, Jack, Gordon Guyatt, Gregory W. Albers, Robert A. Harrington, & Holger J. Schünemann. (2008). Antithrombotic and Thrombolytic Therapy. CHEST Journal. 133(6). 110S–112S. 201 indexed citations
18.
Hasdai, David, Robert A. Harrington, Judith S. Hochman, et al.. (2000). Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. Journal of the American College of Cardiology. 36(3). 685–692. 97 indexed citations
19.
20.
Hillegass, William B., Brigitta C. Brott, Eric B. Haura, et al.. (1995). 1017-71 Patient-Specific Heparin Dosing During Angioplasty. Journal of the American College of Cardiology. 25(2). 391A–391A. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sanjit S. Jolly Breakdown of academic impact, for papers by Sarah H. O’Brien Breakdown of academic impact, for papers by Robert C. Pendleton Breakdown of academic impact, for papers by Flemming Hald Steffensen Breakdown of academic impact, for papers by Daniela Poli Breakdown of academic impact, for papers by David F.M. Brown Breakdown of academic impact, for papers by Ji Zhou Breakdown of academic impact, for papers by Lara A Kahale Breakdown of academic impact, for papers by Christine Demers Breakdown of academic impact, for papers by Sunil Agarwal
Rankless by CCL
2026